STAT+: Lilly’s breast cancer combo wins approval

URL has been copied successfully!

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hi! Today we have some consolidation in radiopharma, an early ADHD signal for orexin agonists, and a call from Reed Jobs to double NIH funding.

I like that Jobs wants biology to be treated as a space race. I also want more racing to space. 

Continue to STAT+ to read the full story…

Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here